First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation | FBTURegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | -2.8 | 7.3 | -3.6 | -7.3 | |
+/-Cat | - | 6.2 | 15.1 | -2.3 | -3.5 | |
+/-B’mrk | - | -3.1 | 4.8 | -10.9 | -13.7 | |
Category: Sector Equity Biotechnology | ||||||
Category Benchmark: Morningstar Gbl Biotechnolo... |
Key Stats | ||
Closing Price 01/05/2024 | USD 17.64 | |
Day Change | 1.77% | |
Morningstar Category™ | Sector Equity Biotechnology | |
Volume | 0 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | IE00BL0L0H60 | |
Fund Size (Mil) 01/05/2024 | USD 4.90 | |
Share Class Size (Mil) 01/05/2024 | USD 4.90 | |
Ongoing Charge 01/01/2023 | 0.60% |
Investment Objective: First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation | FBTU |
The Fund seeks investment results that correspond generally to the price and yield (before the Fund’s fees and expenses) of an equity index called the NYSE Arca Biotechnology Index℠ (the “Index”). |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Not Disclosed 27/05/2020 | ||
Inception Date 27/05/2020 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
NYSE Arca Biotechnology TR USD | Morningstar Gbl Biotechnology NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation | FBTU | 01/05/2024 |
|
|
Top 5 Holdings | Sector | % |
BeiGene Ltd ADR | Healthcare | 3.70 |
Intra-Cellular Therapies Inc | Healthcare | 3.69 |
United Therapeutics Corp | Healthcare | 3.67 |
Biogen Inc | Healthcare | 3.65 |
Neurocrine Biosciences Inc | Healthcare | 3.55 |
Increase Decrease New since last portfolio | ||
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation | FBTU |